164 related articles for article (PubMed ID: 32619635)
21. Evaluating the toxicity of novel Zn-DTPA tablet formulation in dogs and rats.
Shankar GN; Potharaju S; Green CE
Drug Dev Res; 2014 Feb; 75(1):37-46. PubMed ID: 24648048
[TBL] [Abstract][Full Text] [Related]
22. [An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].
Hayashi T; Yamaguchi S; Kito S; Tanaka G; Kurokawa K; Hirota T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():527-44. PubMed ID: 9021660
[TBL] [Abstract][Full Text] [Related]
23. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Han J; Shin HC; Kim JC; Kim B
Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
25. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
26. A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in beagle dogs.
Teo SK; Stirling DI; Thomas SD; Evans MG; Khetani VD
Int J Toxicol; 2003; 22(3):215-26. PubMed ID: 12851154
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical pharmacokinetics and acute toxicological evaluation of a monastrol derivative anticancer candidate LaSOM 65 in rats.
Torres BG; Uchôa Fde T; Pigatto MC; Azeredo FJ; Haas SE; Dallegrave E; Canto RF; Eifler-Lima VL; Dalla Costa T
Xenobiotica; 2014 Mar; 44(3):254-63. PubMed ID: 23937080
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
[TBL] [Abstract][Full Text] [Related]
29. Subchronic and chronic safety studies with genistein in dogs.
McClain RM; Wolz E; Davidovich A; Pfannkuch F; Bausch J
Food Chem Toxicol; 2005 Oct; 43(10):1461-82. PubMed ID: 15885867
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of safety of modified-Danggui Buxue Tang in rodents:immunological, toxicity and hormonal aspects.
Xie JH; Chen ZW; Pan YW; Luo DM; Su ZR; Chen HM; Qin Z; Huang SQ; Lei G
J Ethnopharmacol; 2016 May; 183():59-70. PubMed ID: 26732632
[TBL] [Abstract][Full Text] [Related]
32. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
33. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats.
Wang Y; Wang H; Zhang L; Zhang Y; Sheng Y; Deng G; Li S; Cao N; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 Jun; 238():111866. PubMed ID: 30970283
[TBL] [Abstract][Full Text] [Related]
34. Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.
van der Ark PD; Golor G; van Nueten L; Nandy P; de Boer P
J Psychopharmacol; 2018 Dec; 32(12):1330-1340. PubMed ID: 30182786
[TBL] [Abstract][Full Text] [Related]
35. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): IV. Assessment of the repeated-dose toxicological potential of synthesized L-valyl-L-prolyl-L-proline in male and female rats and dogs.
Nakamura Y; Bando I; Mennear JH; Bernard BK
Int J Toxicol; 2005; 24 Suppl 4():25-39. PubMed ID: 16419577
[TBL] [Abstract][Full Text] [Related]
36. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
[TBL] [Abstract][Full Text] [Related]
37. 26-week repeated oral dose toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in beagle dogs.
Yimam M; Lee YC; Jia Q
Regul Toxicol Pharmacol; 2016 Jul; 78():66-77. PubMed ID: 27125835
[TBL] [Abstract][Full Text] [Related]
38. [Single and 4-week oral toxicity studies of prulifloxacin (NM441) in aged dogs].
Ihara T; Akune A; Nakama K; Chihaya Y; Nagata R; Sumi N; Asaoka H; Shindo Y
J Toxicol Sci; 1996 Jun; 21 Suppl 1():149-69. PubMed ID: 8709158
[TBL] [Abstract][Full Text] [Related]
39. Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumors.
Goldman J; Eckhardt SG; Borad MJ; Curtis KK; Hidalgo M; Calvo E; Ryan DP; Wirth LJ; Parikh A; Partyka J; Faessel H; Gangolli E; Stewart S; Rosen LS; Bowles DW
Clin Cancer Res; 2015 Mar; 21(5):1002-9. PubMed ID: 25501576
[TBL] [Abstract][Full Text] [Related]
40. A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer.
Rizvi NA; Humphrey JS; Ness EA; Johnson MD; Gupta E; Williams K; Daly DJ; Sonnichsen D; Conway D; Marshall J; Hurwitz H
Clin Cancer Res; 2004 Mar; 10(6):1963-70. PubMed ID: 15041713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
